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Abstract The envelope glycoproteins E1 and E2 of Sindbis
virus are palmitoylated at cysteine residues within their
transmembrane domains (E1 at position 430, and E2 at positions
388 and 390). Here, we investigated the in vitro membrane fusion
activity of Sindbis virus variants (derived from the Toto 1101
infectious clone), in which the E1 C430 and/or E2 C388/390
residues had been substituted for alanines. Both the E1 and E2
mutant viruses, as well as a triple mutant virus, fused with
liposomes in a strictly low-pH-dependent manner, the fusion
characteristics being indistinguishable from those of the parent
Toto 1101 virus. These results demonstrate that acylation of the
transmembrane domain of Sindbis virus E1 and E2 is not
required for expression of viral membrane fusion
activity. ß 2001 Federation of European Biochemical Soci-
eties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Sindbis virus (SIN), the prototype member of the genus
alphavirus of the family Togaviridae, contains three major
structural proteins: the capsid protein, C, and two envelope
glycoproteins, E1 and E2 [1^3]. The E1 and E2 proteins,
which mediate the infectious host cell entry of the virus, are
exposed on the viral surface as 80 trimeric spikes each con-
sisting of three E1/E2 heterodimers. E1 and E2 are type-I
integral membrane proteins with a single transmembrane an-
chor sequence and a very small C-terminal domain located at
the internal half of the viral membrane. The transmembrane
sequences of E1 and E2 contain a number of cysteine residues,
which are conserved among most of the members of the al-
phavirus genus and represent potential sites for covalent at-
tachment of long-chain fatty acids. In SIN, these cysteine
residues, at E1 position 430 and E2 positions 388 and 390,
indeed appear to be palmitoylated [4].
Not only the spike proteins of alphaviruses, but in fact
many transmembrane glycoproteins of animal viruses have
been shown to be acylated [5^7]. These include the G protein
of vesicular stomatitis virus [8], the hemagglutinin (HA) of
in£uenza virus [9^13] and the transmembrane subunit of the
envelope glycoproteins of human and simian immunode¢-
ciency viruses [14]. Although modi¢cation with long-chain
fatty acids thus appears to be a common phenomenon among
viral transmembrane proteins, the biological function of acy-
lation remains elusive. Several investigators have used site-
directed mutagenesis in order to selectively replace the cys-
teine residues that provide sites for acylation. Such modi¢ed
proteins have been studied after expression in cultured cells or
in systems generating recombinant viruses. However, con£ict-
ing results have been obtained with regard to the role that
spike protein acylation plays in the life cycle of the viruses
involved. Particularly, the potential function of fatty acids in
the membrane fusion activity of viral spikes, such as the in-
£uenza virus HA, has remained controversial [9,10,13,15^19].
With regard to SIN, studies involving site-speci¢c mutagen-
esis have demonstrated that deacylation of the transmem-
brane domains of the E1 and/or E2 spike glycoproteins slows
down virus growth early in infection [4]. Furthermore, these
deacylation mutant viruses are more sensitive to treatment
with detergent compared with wild-type SIN [4]. Little is
known about the potential e¡ect of spike protein deacylation
on the membrane fusion activity of SIN. However, the fact
that the E1 and/or E2 deacylation SIN mutants infect a vari-
ety of cell types [4] suggests that the viral life cycle, including
the membrane fusion step, is unlikely to be grossly a¡ected by
lipid modi¢cation.
Here, we studied the e¡ect of deacylation of the transmem-
brane domains of SIN glycoproteins E1 and E2 on the viral
membrane fusion capacity. Fusion of SIN virus derived from
the infectious clone Toto 1101 and of several acylation mu-
tants was evaluated in a liposomal model system on the basis
of both lipid mixing and contents mixing. It is demonstrated
that SIN fuses rapidly and e⁄ciently with liposomes in a
strictly low-pH-dependent manner. Moreover, deacylation of
the transmembrane domains of E1 and/or E2 has no e¡ect on
the membrane fusion characteristics of the virus.
2. Materials and methods
2.1. Acylation mutant SIN viruses
A cDNA, containing the Toto 1101 infectious clone of SIN virus
[20], as well as three acylation mutant cDNAs, were generously pro-
vided by Dr. Milton Schlesinger (Washington University, St. Louis,
MO, USA). In the ¢rst acylation mutant, the transmembrane cysteine
at E1 position 430 was replaced by an alanine (E1:C430A), which
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results in an almost complete lack of palmitoylation of E1 and a
minor reduction in palmitoylation of E2 [4]. In the second mutant,
the cysteines at E2 positions 388 and 390 were replaced by alanines
(E2:C388A-C390A), resulting in a reduction of E1 and E2 palmitoy-
lation by about 50% and 70%, respectively [4]. The third mutant, with
all three transmembrane cysteine mutations in E1 and E2 (E1:C430A/
E2:C388A-C390A), is completely devoid of E1 palmitoylation and
has about 30% palmitoylation of E2 [4]. The residual fatty acid bind-
ing to E2 in the presence of the C388A and C390A mutations pre-
sumably arises from acylation at other cysteine residues in the cyto-
plasmic domain of the protein [21].
2.2. Production and characterization of virus particles
For the production of virus particles, RNA was synthesized and
transfected into baby hamster kidney cells (BHK-21) by electropora-
tion, as described previously [22]. Viruses released from cells at 20 h
post-transfection were harvested, and these stocks were subsequently
used directly for the production of pyrene- and [35S]methionine-la-
beled viruses, essentially as described before for Semliki Forest virus
(SFV) [23,24] or SIN [25]. The concentration of the virus preparations
was determined by lipid phosphate [26] and protein [27] analysis. The
purity of the virus particles was con¢rmed by SDS^PAGE. Viral in-
fectivity was determined by titration on BHK-21 cells in 96-well
plates.
2.3. Preparation of liposomes
Liposomes (large unilamellar vesicles) were prepared in 5 mM
HEPES, 150 mM NaCl, 0.1 mM EDTA, pH 7.4 (HNE) by subjection
of lipid mixtures, dried from chloroform solution, to ¢ve cycles of
freezing and thawing and subsequent extrusion [28] through 0.2-Wm
¢lters (Nuclepore Inc., Pleasanton, CA, USA) in a LiposoFast mini-
extruder (Avestin, Ottawa, Canada). Liposomes consisted of phos-
pholipids (Avanti Polar Lipids, Alabaster, AL, USA) and cholesterol
(Chol, Sigma Chem. Co., St Louis, MO, USA). The phospholipids
were phosphatidylcholine (PC) derived from egg yolk, phosphatidyl-
ethanolamine (PE) prepared by transphosphatidylation of egg-PC,
and sphingomyelin (SPM) from egg yolk, mixed with Chol in a molar
ratio of 1:1:1:1.5. Trypsin-containing liposomes were prepared like-
wise, only in this case lipids were dispersed in HNE containing 10 mg/
ml trypsin (Fluka Chemie Ag, Buchs, Switzerland). The trypsin-con-
taining liposomes were separated from free trypsin by gel ¢ltration on
a Sephadex G-100 column in HNE. The phospholipid concentration
of the liposome preparations was determined by phosphate analysis
[26].
2.4. Fusion assays
Fusion of pyrene-labeled SIN with liposomes was monitored on-
line in an AB2 £uorometer (SLM/Aminco, Urbana, IL, USA), as
described previously [25]. Brie£y, pyrene-labeled SIN (0.5 WM viral
phospholipid) and liposomes (200 WM phospholipid) were mixed in a
volume of 0.665 ml in HNE, in a quartz cuvette, magnetically stirred
and maintained at 37‡C. At t = 0 s, fusion was initiated by the addi-
tion of 0.035 ml of 0.1 M MES, 0.2 M acetic acid, pre-titrated with
NaOH to achieve the ¢nal desired pH. The fusion scale was adjusted
such that the initial pyrene excimer £uorescence at 480 nm represented
0% fusion. The 100% fusion value was determined after addition of
0.035 ml of 0.2 M octaethylene glycol monododecyl ether (Fluka
Chemie AG). The initial rate of fusion was determined from the
tangent to the ¢rst part of the curve. The extent of fusion was deter-
mined 60 s after acidi¢cation.
Fusion of SIN with liposomes was also assessed by using a contents
mixing assay based on degradation of the viral capsid protein by
trypsin, initially encapsulated in the liposomes [25,29,30]. Brie£y,
[35S]methionine-labeled virus (0.5 WM phospholipid) was incubated
with trypsin-containing PC/PE/SPM/Chol liposomes (200 WM lipo-
somal phospholipid) in the presence of 125 Wg/ml trypsin inhibitor
(Boehringer, Mannheim, Germany) in the external medium, at
37‡C. The mixture was acidi¢ed, under continuous stirring, to the
desired pH with 0.1 M MES, 0.2 M acetic acid, as described above.
After 30 s, samples were neutralized by the addition of a pre-titrated
volume of 0.1 M NaOH, and further incubated for 1 h at 37‡C.
Subsequently, samples were analyzed by SDS^PAGE, the protein
bands being visualized by autoradiography. Quanti¢cation of the viral
proteins was done by phosphorimaging analysis using Image Quant
3.3 software (Molecular Dynamics, Sunnyvale, CA, USA).
3. Results
3.1. Low-pH-dependent fusion of pyrene-labeled SIN with
liposomes
Fusion of SIN was measured on-line in a liposomal model
system, using a lipid mixing assay based on pyrene excimer
£uorescence [23^25]. In order to exclude any potential e¡ects
of the £uorescence labeling procedure on the biological prop-
erties of the virus, we ¢rst evaluated the speci¢c infectivities of
pyrene-labeled Toto 1101 and acylation mutant SIN virus
preparations. Viral infectivity was determined by titration
on BHK-21 cells and related to the number of virus particles
present based on biochemical analyses [25]. In all cases a
particle to infectious unit ratio of 4^5 was found, similar to
that seen in unlabeled virus (data not shown). These results
demonstrate that neither the £uorescence labeling procedure
nor the presence of the acylation mutations in E1 and/or E2
had any signi¢cant e¡ect on the speci¢c infectivity of the
viruses.
The pyrene fusion assay relies on a decrease of pyrene ex-
cimer £uorescence owing to dilution of pyrene-labeled phos-
pholipids from the viral into the liposomal membrane. This
decrease can be translated directly to the extent of fusion,
since each individual fusion event results in a large dilution
of the probe and, thus, in an essentially complete disappear-
ance of the excimer £uorescence intensity of the virus particle
involved. Fig. 1 presents the fusion kinetics of pyrene-labeled
Toto 1101 SIN virus with PC/PE/SPM/Chol liposomes. At pH
4.6, the virus fused rapidly and e⁄ciently with the liposomes,
the extent of fusion being approximately 55% at 10 s after
acidi¢cation of the virus-liposome mixture (curve a). With
increasing pH, fusion became slower and less extensive (curves
b, c). At pH 7.4 there was no detectable fusion (curve d). We
also measured fusion of pyrene-labeled Toto 1101 SIN virus
with liposomes lacking either SPM or Chol or both, and ob-
served that fusion was absent (data not shown). These results
indicate that the membrane fusion activity of SIN derived
from the Toto 1101 infectious clone is triggered by a mildly
acidic pH and exhibits a similar overall lipid dependence as
Fig. 1. Low-pH-dependent fusion of pyrene-labeled SIN derived
from cDNA clone Toto 1101 with liposomes. Fusion of pyrene-la-
beled SIN Toto 1101 with PC/PE/SPM/Chol liposomes was mea-
sured on-line at 37‡C as described in Section 2. Final concentrations
of virus and liposomes corresponded to 0.5 WM and 200 WM phos-
pholipid, respectively. Curve a, pH 4.6; curve b, pH 5.0; curve c,
pH 5.75; curve d, pH 7.4.
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fusion of wild-type SIN (laboratory-adapted strain AR339)
[25] or SFV [24,31].
3.2. Fusion characteristics of SIN acylation mutants
Fig. 2 presents the fusion kinetics of the three acylation
mutant SIN viruses, E1:C430A, E2:388A/C390A, and
E1:C430A/E2:C388-C390A, in comparison with the original
Toto 1101 virus. Clearly, the fusion kinetics of the acylation
mutants were indistinguishable from those of the unmodi¢ed
virus. Importantly, none of the viruses had any signi¢cant
fusion activity at neutral pH.
Fig. 3 compares the detailed pH dependence of Toto 1101
(open triangles) and the acylation mutant virus E1:C430A/
E2:C388A-C390A (closed triangles). Panel A shows the initial
rate of fusion as a function of the pH, determined from the
tangent to the ¢rst part of the fusion curves. Rates were very
similar for unmodi¢ed and acylation mutant viruses ranging
from pH 4.0 to pH 7.4. Fig. 3B presents the extent of fusion
as a function of pH measured 60 s after acidi¢cation. Again,
throughout the pH range from 4.0 to 7.4, no di¡erences were
observed between the unmodi¢ed and acylation mutant SIN.
Under optimal conditions, 18^20% of the virus particles fused
within the ¢rst second after acidi¢cation, with an extent of
fusion of 60% at 60 s post-acidi¢cation. The pH threshold for
fusion was 6.0 for both viruses. The acylation mutant viruses
E1:C430A and E2:C388A-C390A gave essentially identical
results in terms of the initial rate and extent of fusion (data
not shown).
3.3. Contents mixing of [35S]methionine-labeled SIN with
trypsin-containing liposomes
In the above experiments fusion was evaluated on the basis
of lipid mixing. Another, very stringent, criterion for fusion
involves the coalescence of the interior of the virus with the
liposomal lumen. Contents mixing was assayed as the degra-
dation of the viral capsid protein by trypsin, initially encapsu-
lated in the liposomes. Fig. 4A shows the capsid degradation
of SIN Toto 1101 and the acylation mutant virus E1:C430A/
E2:C388A-C390A. In both cases, incubation of the virus with
trypsin-containing liposomes at pH 4.6 resulted in the degra-
dation of a substantial fraction of the capsid protein (lanes
a,d). At pH 7.4 no capsid degradation was observed (lanes
b,e). The controls, in which the viruses were incubated with
empty liposomes at pH 4.6, did not show degradation of the
capsid protein either (lanes c,f). The ratio of the radioactivity
of the capsid band relative to the total radioactivity (C/
[C+E1+E2]) of the samples incubated at pH 7.4 and the con-
trol samples with empty liposomes was close to 0.4, as ex-
pected on the basis of the number of methionine residues in
the SIN structural proteins [2]. Complete degradation of the
capsid protein was observed when Triton X-100 was added to
the reaction mixture, in the absence of trypsin inhibitor (re-
sults not shown). Fig. 4B shows the extent of capsid degrada-
tion as function of the pH, quanti¢ed by phosphorimaging.
For SIN Toto 1101, incubated at pH 4.6, approximately 70%
of the capsid protein was degraded, whereas pH 5.0 and pH
5.5 the corresponding values were 41% and 19%, respectively.
With the triple acylation mutant virus, E1:C430A/E2:C388A-
C390A, we detected an extent of capsid degradation of 72% at
pH 4.6, 45% at pH 5.0, and 25% at pH 5.5. Similar results
were obtained with the separate E1 or E2 acylation mutant
Fig. 2. Low-pH-dependent fusion of pyrene-labeled acylation mu-
tant SIN viruses with liposomes. Fusion of pyrene-labeled acylation
mutant viruses with liposomes was measured at pH 4.6 and 7.4, as
described in the legend to Fig. 1. Curves a, SIN Toto 1101; curves
b, E1:C430A; curves c, E2:C388A-C390A; curves d, E1:C430A/
E2:C388A-C390A.
Fig. 3. Comparison of the pH dependence of fusion of pyrene-la-
beled acylation mutant and SIN Toto 1101 viruses. Fusion of SIN
Toto 1101 (open triangles) and the acylation mutant virus
E1:C430A/E2:C388A-C390A (closed triangles) was determined at
di¡erent pH values, as described in the legend to Fig. 1. A: The ini-
tial rates of fusion were determined from the tangents to the ¢rst
parts of the fusion curves. B: The extents of fusion were determined
60 s after acidi¢cation.
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viruses (results not shown). The extents of capsid protein deg-
radation seen in the pH range from 4.6 to 5.5 (Fig. 4B) are
very similar to the corresponding extents of lipid mixing ob-
served in the pyrene £uorescence assay (Fig. 3B).
4. Discussion
The results presented in this paper demonstrate that SIN
derived from the infectious clone Toto 1101 fuses rapidly and
e⁄ciently with receptor-free Chol- and sphingolipid-contain-
ing liposomes in a strictly low-pH-dependent manner. Fusion
was evaluated on the basis of both membrane lipid mixing
and internal contents mixing between the virus and the lipo-
somes. The pH dependence of fusion of the Toto 1101 virus is
very similar to that of the wild-type, laboratory-adapted, SIN
strain AR339 [25] and argues strongly for a cell entry mech-
anism of SIN involving receptor-mediated endocytosis and
acid-induced fusion of the viral envelope with the endosomal
membrane. This is entirely consistent with recent observations
of Glomb-Reinmund and Kielian [32]. These investigators
showed that infection of BHK-21 cells by SIN is inhibited
by agents that interfere with endosomal acidi¢cation, such
as NH4Cl, ba¢lomycin or concanamycin. Further support
for a cell entry mechanism of SIN involving receptor-medi-
ated endocytosis was provided by DeTulleo and Kirchhausen
[33], who observed that BHK-21 cell infection by SIN is af-
fected by a mutated form of dynamin which inhibits the bud-
ding of clathrin-coated vesicles.
In the light of this fairly convincing evidence, it is intriguing
that quite recently [34] Brown and coworkers have presented
data which support their previous suggestion [35,36] that ex-
posure to an acidic pH may not be an obligatory step in the
infection of cells by alphaviruses. These investigators observed
that the infection of mosquito cells by SIN was not blocked
by chloroquine under conditions such that the drug did raise
the pH of the endosomal compartment of the cells [34].
Although it is possible that alphaviruses use di¡erent routes
of infection in vertebrate and insect cells, our previous [23^
25,37] and present studies in model systems, designed to spe-
ci¢cally address the issue of alphavirus fusion activation,
strongly argue for exposure to a mildly acidic pH being an
essential step in the triggering of the fusion process.
The principal result of this study demonstrates that acyla-
tion of the transmembrane domains of the SIN glycoproteins
E1 and E2 is not required for expression of viral membrane
fusion activity. Indeed, deacylation of E1 and/or E2 has no
e¡ect on the kinetics or the detailed pH dependence of the
fusion process. This conclusion is in agreement with similar
results obtained for other enveloped viruses, such as vesicular
stomatitis virus [8] and human and simian immunode¢ciency
viruses [14]. The potential role of acylation in the membrane
fusion activity of in£uenza HA, however, remains controver-
sial. HA-mediated fusion has been studied extensively in cul-
tured cells expressing the isolated HA, with erythrocytes or
erythrocyte ghosts serving as target membranes. In such sys-
tems, deacylation of HA does not a¡ect membrane lipid mix-
ing, as measured by £uorescence dequenching of the £uoro-
phore R18 [17,19]. Likewise, deacylation has been observed to
have little e¡ect on syncytia formation mediated by HA ex-
pressed on the cell surface [10,11]. By contrast, other investi-
gators have reported distinct e¡ects of deacylation of HA on
various stages of the fusion process, including initial fusion
pore £ickering [15] and late fusion pore dilation as assessed by
syncytia formation [9,19]. It is possible that this apparent
discrepancy is, at least in part, a consequence of the fusion
process being primarily studied in HA-expressing cells rather
than with virus. In these cell systems the surface density of
HA may vary considerably and also its biological activity may
be a¡ected when it is expressed in the absence of the M2
protein [38]. It is a major advantage of our present study
that it involves the use of whole virus, derived from a
cDNA clone, rather than SIN envelope glycoproteins ex-
pressed on the surface of cultured cells. Similar approaches
followed for in£uenza, involving reverse genetics and the gen-
eration of mutant virions, however, have again resulted in
con£icting conclusions. Zurcher et al. [16] reported that de-
acylation of HA a¡ects virus assembly, whereas little e¡ect on
either assembly or infectivity was observed by others
[18,39,40].
With regard to alphaviruses, SIN in particular, the lack of
e¡ect of E1 and/or E2 deacylation on viral membrane fusion
activity, reported here, and the limited e¡ects on virus assem-
Fig. 4. Degradation of the viral capsid protein by trypsin, initially
encapsulated in the liposomes. The trypsin fusion assay was carried
out as described in Section 2. Final concentrations of
[35S]methionine-labeled virus and trypsin-containing PC/PE/SPM/
Chol liposomes corresponded to 0.5 WM and 200 WM phospholipid,
respectively. A: Viral structural proteins of SIN Toto 1101 (lanes a^
c) and acylation mutant E1:C430A/E2:C388A-C390A (lanes d^f),
visualized by autoradiography. Lanes a and d, trypsin-containing
liposomes at pH 4.6; lanes b and e, trypsin-containing liposomes at
pH 7.4; lanes c and f, empty liposomes at pH 4.6. B: Quanti¢cation
of the extent of capsid protein degradation on the basis of the ratio
C/[C+E1+E2] by phosphorimaging analysis. The ratios C/
[C+E1+E2] of the controls, in which empty liposomes were incu-
bated with the viruses under otherwise identical conditions, were
taken as the 100% values. Solid bars, SIN Toto 1101; hatched bars,
E1:C430A/E2:C388A-C390A.
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bly and release [6] explain the observation made by us in the
present study and by others before [6] that deacylation mutant
viruses are fully infectious on cultured cells, exhibiting normal
speci¢c infectivity values. On the other hand, the conserved
nature of the cysteine residues in the transmembrane domains
of the E1 and E2 envelope glycoproteins suggests that fatty
acid modi¢cation of these proteins has an important function
in the life cycle of alphaviruses. Our present results suggest
that this biological function is not at the level of the low-pH-
induced virus membrane fusion process.
Acknowledgements: This work was supported by the US National
Institutes of Health (Grant HL 16660), and by The Netherlands Orga-
nization for Scienti¢c Research (NWO) under the auspices of the
Foundation for Chemical Research (CW). We would like to thank
Prof. M. Schlesinger for providing us the cDNAs of the acylation
mutant SIN viruses.
References
[1] Schlesinger, S. and Schlesinger, M.J., Eds. (1986) The Togavir-
idae and Flaviviridae, Plenum, New York.
[2] Strauss, J.H. and Strauss, E.G. (1994) Microbiol. Rev. 58, 491^
562.
[3] Kielian, M. (1995) Adv. Virus Res. 45, 113^151.
[4] Ryan, C., Ivanova, L. and Schlesinger, M.J. (1998) Virology 249,
62^69.
[5] Schmidt, M.F.G. (1982) Virology 116, 327^338.
[6] Schlesinger, M.J., Veit, M. and Schmidt, M.F.G. (1992) in: Lipid
Modi¢cations of Proteins (Schlesinger, M.J., Ed.), pp. 1^20,
CRC, Boca Raton, FL.
[7] Hruby, D.E. and Franke, C.A. (1993) Trends Microbiol. 1, 20.
[8] Whitt, M.A. and Rose, J.K. (1991) Virology 185, 875^878.
[9] Naeve, C.W. and Williams, D. (1990) EMBO J. 9, 3857^3866.
[10] Steinhauer, D.A., Wharton, S.A., Wiley, D.C. and Skehel, J.J.
(1991) Virology 184, 445^448.
[11] Veit, M., Kretzschmar, E., Kuroda, K., Garten, W., Schmidt,
M.F.G., Klenk, H.-D. and Rott, R. (1991) J. Virol. 65, 2491^
2500.
[12] Naim, H.Y., Amarneh, B., Ktistakis, N.T. and Roth, M.G.
(1992) J. Virol. 66, 7585^7588.
[13] Simpson, D.A. and Lamb, R.A. (1992) J. Virol. 66, 790^803.
[14] Yang, C., Spies, C.P. and Compans, R.W. (1995) Proc. Natl.
Acad. Sci. USA 92, 9871^9875.
[15] Melikyan, G.B., Jin, H., Lamb, R.A. and Cohen, F.S. (1997)
Virology 235, 118^128.
[16] Zurcher, T., Fluo, G. and Palese, P. (1994) J. Virol. 68, 5748^
5754.
[17] Philipp, H.C., Schroth, B., Veit, M., Krumbiegel, M., Herrmann,
A. and Schmidt, M.F.G. (1995) Virology 210, 20^28.
[18] Jin, H., Subbarao, K., Bagai, S., Leser, G.P., Murphy, B.R. and
Lamb, R.A. (1996) J. Virol. 70, 1406^1414.
[19] Fischer, C., Schroth-Diez, B., Herrmann, A., Garten, A. and
Klenk, H.-D. (1998) Virology 248, 284^294.
[20] Rice, C.M., Levis, R., Strauss, J.H. and Huang, H.V. (1987)
Virology 61, 3809^3819.
[21] Ivanova, L. and Schlesinger, M.J. (1993) J. Virol. 67, 2546^2551.
[22] Liljestro«m, P., Lusa, S., Huylebroeck, D. and Garo¡, H. (1991)
J. Virol. 65, 4107^4113.
[23] Bron, R., Wahlberg, J.M., Garo¡, H. and Wilschut, J. (1993)
EMBO J. 12, 693^701.
[24] Nieva, J.L., Bron, R., Corver, J. and Wilschut, J. (1994) EMBO
J. 13, 2797^2804.
[25] Smit, J.M., Bittman, R. and Wilschut, J. (1999) J. Virol. 73,
8476^8484.
[26] Bo«ttcher, C.J.F., van Gent, C.M. and Fries, C. (1961) Anal.
Chim. Acta. 24, 203^204.
[27] Peterson, G.L. (1977) Anal. Biochem. 83, 346^356.
[28] Hope, M.J., Bally, M.B., Webb, G. and Cullis, P.R. (1985) Bio-
chim. Biophys. Acta 812, 55^65.
[29] White, J. and Helenius, A. (1980) Proc. Natl. Acad. Sci. USA 77,
3273^3277.
[30] Moesby, L., Corver, J., Erukulla, R.K., Bittman, R. and Wil-
schut, J. (1995) Biochemistry 34, 10319^10324.
[31] Corver, J., Moesby, L., Erukulla, R.K., Reddy, K.C., Bittman,
R. and Wilschut, J. (1995) J. Virol. 69, 3220^3223.
[32] Glomb-Reinmund, S. and Kielian, M. (1998) Virology 248, 372^
381.
[33] DeTulleo, L. and Kirchhausen, T. (1998) EMBO J. 17, 4585^
4593.
[34] Hernandez, R., Luo, T. and Brown, D.T. (2001) J. Virol. 75,
2010^2013.
[35] Cassell, S., Edwards, J. and Brown, D.T. (1984) J. Virol. 52, 857^
864.
[36] Edwards, J. and Brown, D.T. (1991) Virology 182, 28^33.
[37] Wahlberg, J.M., Bron, R., Wilschut, J. and Garo¡, H. (1992)
J. Virol. 66, 7309^7318.
[38] Ohuchi, M., Cramer, A., Vey, M., Ohuchi, R. and Klenk, H.-D.
(1994) J. Virol. 68, 920^926.
[39] Jin, H., Leser, G. and Lamb, R.A. (1994) EMBO J. 13, 5504^
5515.
[40] Yang, C. and Compans, R.W. (1996) Virology 221, 87^97.
FEBS 24920 28-5-01
J.M. Smit et al./FEBS Letters 498 (2001) 57^61 61
